Vestmark Advisory Solutions Inc. Makes New $6.89 Million Investment in Teladoc Health, Inc. (NYSE:TDOC)

Vestmark Advisory Solutions Inc. bought a new stake in Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 319,785 shares of the health services provider’s stock, valued at approximately $6,891,000. Vestmark Advisory Solutions Inc. owned approximately 0.19% of Teladoc Health at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in TDOC. Hexagon Capital Partners LLC grew its position in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $36,000. GAMMA Investing LLC acquired a new stake in shares of Teladoc Health in the 4th quarter worth $41,000. Byrne Asset Management LLC purchased a new position in shares of Teladoc Health during the 3rd quarter worth $60,000. Finally, Van ECK Associates Corp boosted its position in shares of Teladoc Health by 20.3% during the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock valued at $77,000 after acquiring an additional 606 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

TDOC has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Friday, April 26th. DA Davidson decreased their price objective on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. TD Cowen cut their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Finally, Citigroup cut their price objective on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Twelve investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $18.73.

Teladoc Health Stock Down 1.6 %

Teladoc Health stock traded down $0.21 during mid-day trading on Friday, reaching $12.78. 6,206,900 shares of the company’s stock were exchanged, compared to its average volume of 5,358,721. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health, Inc. has a twelve month low of $12.53 and a twelve month high of $30.41. The company has a market cap of $2.17 billion, a P/E ratio of -9.06 and a beta of 0.97. The company has a fifty day moving average of $14.40 and a 200-day moving average of $17.51.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The company had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same quarter in the previous year, the business posted ($0.37) earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. Sell-side analysts expect that Teladoc Health, Inc. will post -1.04 EPS for the current year.

Insider Activity

In related news, CAO Richard J. Napolitano sold 3,765 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the sale, the chief accounting officer now owns 18,077 shares of the company’s stock, valued at $262,478.04. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the transaction, the executive vice president now owns 39,429 shares in the company, valued at approximately $572,509.08. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Richard J. Napolitano sold 3,765 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $54,667.80. Following the sale, the chief accounting officer now owns 18,077 shares of the company’s stock, valued at approximately $262,478.04. The disclosure for this sale can be found here. In the last quarter, insiders sold 138,368 shares of company stock worth $1,989,227. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.